• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.

作者信息

Pagani Gabriele, Conti Federico, Giacomelli Andrea, Bernacchia Dario, Rondanin Rossana, Prina Andrea, Scolari Vittore, Gandolfi Cecilia Eugenia, Castaldi Silvana, Marano Giuseppe, Ottomano Cosimo, Boracchi Patrizia, Biganzoli Elia, Galli Massimo

机构信息

Università degli Studi di Milano, Italy; Infectious Diseases department, III Division, ASST FBF-Sacco, Milano, Italy.

Università degli Studi di Milano, Italy; Infectious Diseases department, III Division, ASST FBF-Sacco, Milano, Italy.

出版信息

J Infect. 2020 Dec;81(6):e10-e12. doi: 10.1016/j.jinf.2020.09.021. Epub 2020 Sep 19.

DOI:10.1016/j.jinf.2020.09.021
PMID:32961253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836634/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/7836634/ca0c7c6ff903/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/7836634/0fd17e5d56c7/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/7836634/ca0c7c6ff903/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/7836634/0fd17e5d56c7/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/7836634/ca0c7c6ff903/gr1_lrg.jpg

相似文献

1
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的血清流行率随年龄显著变化：大规模人群筛查的初步结果。
J Infect. 2020 Dec;81(6):e10-e12. doi: 10.1016/j.jinf.2020.09.021. Epub 2020 Sep 19.
2
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率：封锁后时期的监测策略？]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
3
SARS-CoV-2 seroprevalence in the Vatican City State.梵蒂冈城国的新冠病毒血清流行率。
Eur J Intern Med. 2021 Apr;86:98-99. doi: 10.1016/j.ejim.2021.01.029. Epub 2021 Feb 4.
4
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.SARS-CoV-2 血清阳性率是法国解除隔离的关键因素。
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.04.031. Epub 2020 Apr 29.
5
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.法国岛地区来自撒哈拉以南非洲的HIV患者中SARS-CoV-2血清阳性率高：HIV患者中SARS-CoV-2的血清阳性率
J Infect. 2022 Aug;85(2):e33-e36. doi: 10.1016/j.jinf.2022.05.036. Epub 2022 Jun 2.
6
Potential drawbacks of SARS-CoV-2 seroprevalence surveys.新型冠状病毒2型血清流行率调查的潜在缺点。
J Hosp Infect. 2021 Apr;110:206. doi: 10.1016/j.jhin.2020.12.011. Epub 2020 Dec 21.
7
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.日本东京一家大型国立医院及其附属机构中抗新冠病毒 2 型抗体的血清流行率。
J Infect. 2021 Apr;82(4):e1-e3. doi: 10.1016/j.jinf.2021.01.010. Epub 2021 Jan 29.
8
Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada.加拿大不列颠哥伦比亚省使用产前血清样本检测人群中新冠病毒血清阳性率
J Obstet Gynaecol Can. 2021 Nov;43(11):1242-1243. doi: 10.1016/j.jogc.2021.06.001.
9
Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).罗斯柴尔德基金会医院646名专业人员中SARS-CoV-2的血清阳性率（ProSeCoV研究）。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):595-596. doi: 10.1016/j.accpm.2020.08.003. Epub 2020 Aug 27.
10
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.西班牙巴塞罗那北部大都市区医护人员在第一波大流行后 SARS-CoV-2 IgG 特异性抗体的血清流行率。
PLoS One. 2020 Dec 28;15(12):e0244348. doi: 10.1371/journal.pone.0244348. eCollection 2020.

引用本文的文献

1
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.2020 年 1 月至 12 月，在世界卫生组织欧洲区域广泛推出疫苗接种计划之前，对 SARS-CoV-2 抗体血清流行率进行系统评价，并对证据进行评估。
BMJ Open. 2023 Nov 6;13(11):e064240. doi: 10.1136/bmjopen-2022-064240.
2
Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省HIV阳性和HIV阴性个体中SARS-CoV-2免疫球蛋白G的血清阳性率。
Afr J Lab Med. 2023 Jun 29;12(1):2065. doi: 10.4102/ajlm.v12i1.2065. eCollection 2023.
3
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.
血清流行率和 SARS-CoV-2 在普通人群中的入侵：大流行第一年的范围综述。
PLoS One. 2023 Apr 19;18(4):e0269104. doi: 10.1371/journal.pone.0269104. eCollection 2023.
4
Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 study.农村社区初次感染易感性人群中 SARS-CoV-2 鼻咽拭子检测的决定因素：CHRIS COVID-19 研究。
Pathog Glob Health. 2023 Dec;117(8):744-753. doi: 10.1080/20477724.2023.2191232. Epub 2023 Mar 29.
5
Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of Ghana.加纳大阿克拉地区基于人群的 SARS-CoV-2 感染动态血清流行病学调查。
Sci Rep. 2022 Dec 14;12(1):21582. doi: 10.1038/s41598-022-25598-0.
6
Knowledge of SARS-CoV-2 Epitopes and Population HLA Types Is Important in the Design of COVID-19 Vaccines.了解严重急性呼吸综合征冠状病毒2（SARS-CoV-2）表位和人群人类白细胞抗原（HLA）类型对2019冠状病毒病（COVID-19）疫苗设计至关重要。
Vaccines (Basel). 2022 Sep 24;10(10):1606. doi: 10.3390/vaccines10101606.
7
Trend of expansion of SARS-CoV-2 infection and COVID-19 burden in Gabon (Central Africa) in mid-2021, based on a serological survey.基于血清学调查的2021年年中加蓬（中非）SARS-CoV-2感染扩展趋势及新冠疫情负担
IJID Reg. 2022 Dec;5:13-17. doi: 10.1016/j.ijregi.2022.08.006. Epub 2022 Aug 27.
8
High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia.沙特阿拉伯麦加地区无症状献血者中新冠病毒2型免疫球蛋白G和核糖核酸的高血清阳性率
Vaccines (Basel). 2022 Aug 8;10(8):1279. doi: 10.3390/vaccines10081279.
9
Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.3 至 16 岁儿童中 SARS-CoV-2 血清阳性率的纵向变化：奥格斯堡 Plus 研究。
PLoS One. 2022 Aug 11;17(8):e0272874. doi: 10.1371/journal.pone.0272874. eCollection 2022.
10
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.SARS-CoV-2 在大流行第一年的传播情况：意大利托斯卡纳 2020 年 1 月至 12 月的血清流行率研究。
Viruses. 2022 Jun 30;14(7):1441. doi: 10.3390/v14071441.